CLOSE X
GO

Nippon India Pharma Fund(G)

very highequitypharma & health care
512.96 -4.65(-0.90%) NAV as on 20 Dec 2024
2.76 % 1 M
36.47 % 1 Y
20.88 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.81

As on 30 Nov, 2024
age-icon Age :

20 yrs 6 m

Since 05 06 ,2004
exit_load Exit Load :

1%

aum AUM :

8,638.23 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.76

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Nov 30 ,2024
Others 3.07 %
Equity 96.93 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.52 %
Divi's Laboratories Ltd.9.65 %
Lupin Ltd.7.61 %
Cipla Ltd.5.50 %
Apollo Hospitals Enterprise Ltd.5.13 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs78.24
Hospital & Healthcare Services17.47
Business Support1.23
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)143.39250.18290.14270.59428.87
Net Assets(Rs Crores) (as on 31-Mar-2024) 2189.84 4260.99 4931.89 4304.46 7125.28
Scheme Returns(%)(Absolute)-5.8377.3614.83-6.8558.24
B'mark Returns(%)(Absolute)NANANANANA
Category Rank14/7532/7543/7565/7617/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity512.96-4.65(-0.90%)NAV As on 20 Dec, 202405-Jun-2004Inception Date8,638.23AUM In Cr.36.47%1Y20.88%3Y27.64%5Y21.11%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity38.82-0.22(-0.56%)NAV As on 20 Dec, 202413-Jul-2018Inception Date5,044.63AUM In Cr.49.14%1Y25.86%3Y30.25%5Y23.43%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity425.34-3.87(-0.90%)NAV As on 20 Dec, 202414-Jul-1999Inception Date3,459.68AUM In Cr.44.04%1Y25.17%3Y29.24%5Y16.62%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.82-0.25(-0.81%)NAV As on 20 Dec, 202428-Dec-2015Inception Date1,213.92AUM In Cr.42.34%1Y22.74%3Y27.36%5Y13.34%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors